For UK pharmaceutical and life sciences leaders
A weak MLR process leaves every piece of promotional material exposed to PMCPA scrutiny
One upheld complaint can trigger corrective action, reputational damage, and a closer eye on everything you publish next. Most gaps in promotional compliance trace back to the same structural weaknesses in the MLR review cycle.
Two minutes. Solva follows up with specific MLR process improvement options.
- Promotional materials being flagged by internal compliance checks or external audits for non-adherence to the ABPI Code.
- Increased frequency of PMCPA complaints or inquiries regarding specific marketing campaigns.
- Delays in the approval process for new promotional content due to multiple rounds of revisions and legal scrutiny.
- A perception among sales and marketing teams that compliance is an obstacle rather than an enabler.
- Significant diversion of senior management and legal team resources to address complaints and corrective actions
- Delays in product launches and marketing campaigns due to protracted MLR review cycles
- Significant financial penalties from PMCPA rulings, potentially exceeding £150,000 per breach (PMCPA, 2024)
- Increased legal and compliance costs for investigations and remediation
- Damage to the company's reputation and credibility within the healthcare industry
- Erosion of trust among healthcare professionals and patient groups
No verified UK data available
Source: N/A
Frequently asked questions
Why does this problem persist?
The ABPI Code of Practice governs all promotional activity for prescription medicines in the UK. Companies that don't have a robust medical, legal, and regulatory (MLR) review process for promotional materials risk PMCPA complaints, which are time-consuming, reputationally damaging, and can result in mandatory corrective action.
What is the cost of leaving it unaddressed?
No verified UK data available
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.